Explore the impact of AI in drug discovery as 2026 promises critical clinical results and industry transformations.
Artificial intelligence (AI) tools could begin handling parts of routine hospital documentation this year, according to Roy Jakobs, chief executive officer of Philips ...
From antibiotic resistance to emerging viral threats, the global demand for new medicines is intensifying, yet traditional drug discovery pipelines remain slow and expensive. A new scientific review ...
T Koshy, Founding MD and CEO of ONDC, reflects on governance architecture, MSME safeguards and the growing role of digital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results